Litcius/Paper detail

Prediction and molecular field view of drug resistance in HIV-1 protease mutants

Baifan Wang, Yinwu He, Xin Wen, Zhen Xi

2022Scientific Reports13 citationsDOIOpen Access PDF

Abstract

Abstract Conquering the mutational drug resistance is a great challenge in anti-HIV drug development and therapy. Quantitatively predicting the mutational drug resistance in molecular level and elucidating the three dimensional structure-resistance relationships for anti-HIV drug targets will help to improve the understanding of the drug resistance mechanism and aid the design of resistance evading inhibitors. Here the MB-QSAR (Mutation-dependent Biomacromolecular Quantitative Structure Activity Relationship) method was employed to predict the molecular drug resistance of HIV-1 protease mutants towards six drugs, and to depict the structure resistance relationships in HIV-1 protease mutants. MB-QSAR models were constructed based on a published data set of K i values for HIV-1 protease mutants against drugs. Reliable MB-QSAR models were achieved and these models display both well internal and external prediction abilities. Interpreting the MB-QSAR models supplied structural information related to the drug resistance as well as the guidance for the design of resistance evading drugs. This work showed that MB-QSAR method can be employed to predict the resistance of HIV-1 protease caused by polymorphic mutations, which offer a fast and accurate method for the prediction of other drug target within the context of 3D structures.

Topics & Concepts

Quantitative structure–activity relationshipHIV-1 proteaseDrug resistanceProteaseContext (archaeology)Computational biologyMutantDrugHuman immunodeficiency virus (HIV)MutationBiologyGeneticsBioinformaticsVirologyPharmacologyBiochemistryEnzymeGenePaleontologyHIV/AIDS drug development and treatmentHIV Research and TreatmentPneumocystis jirovecii pneumonia detection and treatment
Prediction and molecular field view of drug resistance in HIV-1 protease mutants | Litcius